New CRO Partner: Labcorp

We are pleased to welcome Labcorp as a new CRO partner. Labcorp is a global leader of innovative and comprehensive laboratory services and drug development support, backed by a worldwide network of laboratories and scientific experts. This partnership connects Mabtech's ELISpot and FluoroSpot assays with Labcorp's Immunology & Immunotoxicology team, giving joint customers a clear path from early discovery work to regulatory-ready data.

Labcorp supports pharmacological assessments of drug compounds from early in vitro research through clinical trials, including specialized immunogenicity testing for biologics, cell and gene therapies, and vaccines. The team's work spans seven global sites, covering both large-molecule and advanced-therapy safety programs, and pairs strong regulatory insight with modern immunoassay and flow cytometry platforms – a combination well suited to Mabtech's technology.

Together, Mabtech and Labcorp aim to give biopharma developers a smoother route from candidate selection to IND-enabling studies, with immune monitoring built on validated, high-sensitivity methods at every stage.

More on IQVIA Laboratories and our other CRO partners.